Sephience

Active Ingredient(s): Sepiapterin
FDA Approved: * July 28, 2025
Pharm Company: * PTC THERAP
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Sephience 250 mg Oral Powder
NDC: 52856-201
Labeler:
Ptc Therapeutics Inc.
Sephience 1000 mg Oral Powder
NDC: 52856-301
Labeler:
Ptc Therapeutics Inc.
Sephience 1000 mg Oral Powder
NDC: 60468-006
Labeler:
Allphamed Pharbil Arzneimittel Gmbh
Sephience 250 mg Oral Powder
NDC: 60468-007
Labeler:
Allphamed Pharbil Arzneimittel Gmbh